| Returns | 1W : 9.4% , 1M : 26.5%,1Y : 61.4% |
| Peers & Returns | 1W | 1M | 1Y |
| ANUH PHARMA | 9.4% | 26.5% | 61.4% |
| SUN PHARMACEUTICAL INDUSTRIES | 2.8% | 10.2% | 40.1% |
| DR REDDYS LABORATORIES | 7.8% | 18.3% | 26.4% |
| DIVIS LABORATORIES | 1.7% | 12% | 63.2% |
| CIPLA | 7.2% | 22.8% | 58.3% |
| BIOCON | -1.4% | 3.4% | 14.3% |
| AUROBINDO PHARMA | 8.5% | 17.7% | 77.9% |
| LUPIN | 5.1% | 6.9% | 28.9% |
| TORRENT PHARMACEUTICALS | 1.5% | 7.8% | 15.5% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
22.1
P/E Calculated based on EPS of 5.71
[ Mar2020 - Standalone Results ] 1.95
P/B Calculated based on Book Value of 64.74
[ Mar2020 - Standalone Results ] 1.83
P/S Calculated based on Revenues of 346.314 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
197% 103% 82% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
